ducovest

MCK:NYE-McKesson Corporation (USD)

EQUITY | Medical Distribution | New York Stock Exchange

Last Closing

USD 539.26

Change

+3.17 (+0.59)%

Market Cap

USD 31.54B

Volume

0.43M

Analyst Target

USD 185.31
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

McKesson Corporation distributes pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs. Its segments include McKesson Distribution Solutions and McKesson Technology Solutions.

Company Website : http://www.mckesson.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

N/A

 USD 38.52B
CAH Cardinal Health Inc

N/A

 USD 26.32B
OMI Owens & Minor Inc

N/A

 USD 2.06B
NVG Nuveen AMT Free Municipal Cred..

N/A

 USD 3.29M

ETFs Containing MCK

UDA:CA Caldwell U.S. Dividend Ad.. 6.04 % 0.00 %

N/A

 CAD 0.04B
PPH VanEck Pharmaceutical ETF 4.70 % 0.36 %

N/A

 USD 0.49B
BGU:CA Bristol Gate Concentrated.. 4.55 % 0.85 %

N/A

 CAD 0.11B
BGU-U:CA Bristol Gate Concentrated.. 4.55 % 0.00 %

N/A

 CAD 0.11B
BLOV:CA Brompton North American L.. 4.42 % 0.00 %

N/A

 CAD 9.64M
CFCV 4.39 % 0.00 %

N/A

 N/A
IYK iShares US Consumer Stapl.. 3.24 % 0.42 %

N/A

 USD 1.26B
PEZ Invesco DWA Consumer Cycl.. 2.91 % 0.60 %

N/A

 USD 0.06B
VALQ American Century STOXX U... 2.11 % 0.29 %

N/A

 USD 0.21B
DEF 0.00 % 0.59 %

N/A

 N/A
DEUS Xtrackers Russell US Mult.. 0.00 % 0.18 %

N/A

 USD 0.15B
EZY 0.00 % 0.38 %

N/A

 N/A
FLAG 0.00 % 1.52 %

N/A

 N/A
FXG First Trust Consumer Stap.. 0.00 % 0.64 %

N/A

 USD 0.44B
ONEO SPDR® Russell 1000 Momen.. 0.00 % 0.20 %

N/A

 USD 0.14B
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

 USD 0.62B
CLRG 0.00 % 0.25 %

N/A

 N/A
BVNSC 0.00 % 0.00 %

N/A

 N/A
RTH VanEck Retail ETF 0.00 % 0.35 %

N/A

 USD 0.20B
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

N/A

 USD 3.00B
RYH 0.00 % 0.40 %

N/A

 N/A
SPYB 0.00 % 0.35 %

N/A

 N/A
SYV 0.00 % 0.60 %

N/A

 N/A
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

N/A

 USD 0.08B
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

 USD 1.13B

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.48% 60% D- 89% A-
Dividend Return 0.13% 33% F 5% F
Total Return 16.61% 60% D- 88% B+
Trailing 12 Months  
Capital Gain 50.99% 80% B- 91% A-
Dividend Return 0.67% 50% F 6% D-
Total Return 51.66% 60% D- 91% A-
Trailing 5 Years  
Capital Gain 360.67% 80% B- 97% N/A
Dividend Return 8.57% 40% F 31% F
Total Return 369.24% 80% B- 97% N/A
Average Annual (5 Year Horizon)  
Capital Gain 34.73% 80% B- 92% A
Dividend Return 35.74% 80% B- 92% A
Total Return 1.01% 40% F 26% F
Risk Return Profile  
Volatility (Standard Deviation) 21.28% 60% D- 54% F
Risk Adjusted Return 167.96% 100% F 100% F
Market Capitalization 31.54B 100% F 97% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.90 60% 33%
Price/Book Ratio 5.04 67% 17%
Price / Cash Flow Ratio 13.40 25% 28%
Price/Free Cash Flow Ratio 16.84 25% 21%
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital 94.66% 100% 99%
Return on Assets 3.63% 100% 61%
Debt to Equity Ratio -249.11% 100% 97%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.